Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kathy Kozak"'
Autor:
Helen Ge, Georgette M. Buga, Junji Watanabe, Yunan Miao, Kathy Kozak, Susan Hama, Mohamad Navab, Alan M. Fogelman, Hsiang-Hui Meng, James C. Liao, Victor Grijalva, Terry D. Lee, Julian P. Whitelegge, Srinivasa T. Reddy, Robin Farias-Eisner, Katherine J. Chou
Publikováno v:
Journal of Biological Chemistry. 282:23698-23707
Studies in both mice and humans suggest that the anti- or proinflammatory nature of high density lipoprotein (HDL) may be a more sensitive predictor of risk for coronary heart disease events. In this study, we report the identification and characteri
Autor:
Satoshi Imaizumi, Mohamad Navab, Brian J. Van Lenten, Srinivasa T. Reddy, Gina Farias-Eisner, Alan C. Wagner, Victor Grijalva, Kathy Kozak, Greg Hough, Gattadahalli M. Anantharamaiah, Feng Su, Alan M. Fogelman, Feng Gao, Malaika W. Amneus, Carey J. Ng, Robin Farias-Eisner
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 107(46)
We examined whether reduced levels of Apolipoprotein A-I (apoA-I) in ovarian cancer patients are causal in ovarian cancer in a mouse model. Mice expressing a human apoA-I transgene had ( i ) increased survival ( P < 0.0001) and ( ii ) decreased tumor
Autor:
Aimee Fourie, An Do, Yulei Wang, Kathy Kozak, Suzie J. Scales, Lisa Ryner, Ron Firestein, Siao Ping Tsai, Yinghui Guan
Publikováno v:
Cancer Research. 73:3213-3213
MUC16 and MSLN are tumor-specific antigens highly prevalent in ovarian and pancreatic cancers and have been used as targets in developing antibody-drug conjugates (ADCs). Development of a sensitive method to quantitatively measure these protein bioma
Autor:
Rajesh Vij, David M. Goldenberg, Jo-Anne Hongo, Weiguang Mao, Xiaoling Xia, Paul Polakis, Sarajane Ross, Janet Tien, Susan D. Spencer, Scott Stawicki, Yan Wu, Kathy Kozak, Ron Firestein
Publikováno v:
Cancer Research. 70:4289-4289
LGR5 (GPR49) is a Wnt pathway downstream target gene. It has already been confirmed that LGR5 gene is up regulated by APC or β-catenin mutation. LGR5 has recently been identified as a biomarker on the human and murine intestinal or colon stem cells.